Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab

被引：27

作者：

Meissner, HC ^{[1
]}

Rennels, MB

Pickering, LK

Hall, CB

机构：

[1] Tufts Univ, New England Med Ctr, Div Pediat Infect Dis, Boston, MA 02111 USA

[2] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA

[3] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA

[4] Univ Rochester, Dept Pediat & Med, Div Infect Dis, Rochester, NY USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2004年 / 23卷 / 03期

关键词：

respiratory syncytial virus; palivizumab; high risk infants;

D O I：

10.1097/01.inf.0000121203.33560.f9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：284 / 285

页数：2

共 12 条

[1] Revised indications for the use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the prevention of respiratory syncytial virus infections [J].

Abramson, JS ;

Baker, CJ ;

Baltimore, RS ;

Bocchini, JA ;

Long, SS ;

McMillan, JA ;

Meissner, HC ;

Powell, KR ;

Prober, CG ;

Rennels, MB ;

Saari, TN ;

Weiner, LB ;

Blackmon, L ;

Batton, DG ;

Bell, EF ;

Denson, SE ;

Engle, WA ;

Kanto, WP ;

Martin, GI ;

Stark, AR .

PEDIATRICS, 2003, 112 (06) :1447-1452

[2]

Abramson JS, 2003, PEDIATRICS, V112, P1442

[3] Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid [J].

Boyce, TG ;

Mellen, BG ;

Mitchel, EF ;

Wright, PF ;

Griffin, MR .

JOURNAL OF PEDIATRICS, 2000, 137 (06) :865-870

[4] Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines [J].

Durbin, AP ;

Karron, RA .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :1668-1677

[5] Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease? [J].

Elhassan, NO ;

Stevens, TP ;

Sorbero, MES ;

Dick, AW ;

Guillet, R ;

Hall, CB .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (11) :939-942

[6]

Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211

[7] Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999 [J].

Leader, S ;

Kohlhase, K .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (07) :629-632

[8] Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion [J].

Meissner, HC ;

Welliver, RC ;

Chartrand, SA ;

Law, BJ ;

Weisman, LE ;

Dorkin, HL ;

Rodriguez, WJ .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (03) :223-231

[9]

Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531

[10] Bronchiolitis-associated hospitalizations among US children, 1980-1996 [J].

Shay, DK ;

Holman, RC ;

Newman, RD ;

Liu, LL ;

Stout, JW ;

Anderson, LJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1440-1446

← 1 2 →